T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Equity Lifestyle Properties
ELS
$12.4B
| $38.2M | 0.01% |
955,290
+318
| +0% | +$11.5K |
|
|
BHBK
877
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $38.1M | 0.01% |
2,583,532
+670,497
| +35% | +$9.61M |
|
|
RWT
878
Redwood Trust
RWT
$592M
| $38.1M | 0.01% |
2,758,195
-144,100
| -5% | -$1.93M |
|
|
ACHN
879
DELISTED
Achillion Pharmaceuticals
ACHN
| $38M | 0.01% |
4,866,919
+71,712
| +1% | +$615K |
|
880
Zumiez
ZUMZ
$318M
| $37.6M | 0.01% |
2,628,666
+348,266
| +15% | +$5.54M |
|
881
Vale
VALE
$61.4B
| $37.6M | 0.01% |
7,429,701
-123,679
| -2% | -$579K |
|
882
Marathon Petroleum
MPC
$97.8B
| $37.5M | 0.01% |
989,028
-100
| -0% | -$3.67K |
|
|
TLMR
883
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $37.4M | 0.01% |
1,951,950
-62,900
| -3% | -$1.21M |
|
884
Teradyne
TER
$63B
| $37.3M | 0.01% |
1,896,273
-173,783
| -8% | -$3.43M |
|
885
Preferred Bank
PFBC
$1.26B
| $37M | 0.01% |
1,280,813
+16,690
| +1% | +$519K |
|
|
CSS
886
DELISTED
CSS Industries, Inc.
CSS
| $36.9M | 0.01% |
1,375,723
+4,013
| +0.3% | +$110K |
|
|
GTLS
887
DELISTED
Chart Industries
GTLS
| $36.9M | 0.01% |
1,528,470
-11,170
| -0.7% | -$276K |
|
888
Hercules Capital
HTGC
$3.11B
| $36.8M | 0.01% |
2,964,210
-2,560
| -0.1% | -$31.1K |
|
889
Five Below
FIVE
$13.2B
| $36.7M | 0.01% |
790,857
-7,063
| -0.9% | -$295K |
|
|
ILG
890
DELISTED
ILG, Inc Common Stock
ILG
| $36.7M | 0.01% |
2,306,203
+478,386
| +26% | +$6.83M |
|
891
Culp Inc
CULP
$43.8M
| $36.5M | 0.01% |
1,321,607
+130
| +0% | +$3.54K |
|
892
Compass Diversified
CODI
$908M
| $36.5M | 0.01% |
2,200,710
-5,900
| -0.3% | -$94.8K |
|
|
FRED
893
DELISTED
Fred's Inc
FRED
| $36.4M | 0.01% |
2,256,604
-1,800
| -0.1% | -$26.6K |
|
894
Brown-Forman Class B
BF.B
$12.8B
| $36.1M | 0.01% |
1,130,547
+3,338
| +0.3% | +$103K |
|
|
PSTB
895
DELISTED
Park Sterling Corp.
PSTB
| $36.1M | 0.01% |
5,089,197
+1,178,500
| +30% | +$8.41M |
|
896
American Vanguard Corp
AVD
$64M
| $35.8M | 0.01% |
2,369,224
-14,712
| -0.6% | -$217K |
|
897
Skyworks Solutions
SWKS
$10.5B
| $35.5M | 0.01% |
560,281
-23,210
| -4% | -$1.58M |
|
|
SASR
898
DELISTED
Sandy Spring Bancorp Inc
SASR
| $35.4M | 0.01% |
1,217,950
-21,400
| -2% | -$607K |
|
899
Carter's
CRI
$1.43B
| $35.2M | 0.01% |
330,895
-3,578
| -1% | -$369K |
|
900
Helen of Troy
HELE
$696M
| $35.2M | 0.01% |
342,016
+8,006
| +2% | +$808K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.